Custom-made GMP peptides

Gepubliceerd

20 februari 2025

Plaats van uitvoering

NL

Procedure

Overig

Documenten

1

Aankondigingsnummer

368193

Referentie

TN-512552

Officiële bron

Officiële bron

CPV-codes

• 33600000-6Farmaceutische producten
• 33696300-8Chemische reagentia

Beschrijving

The Department of Medical BioSciences from Radboudumc has been award a KWF grant for the PROTECT-lynch study. The main goal of the PROTECT-lynch study is a new treatment option for LS patients significantly improving the quality of life of LS patients and most likely the prognosis (occurrence of Lynch-related cancer(s). Standard care for healthy LS patients currently consists of undergoing intensive surveillance programs that do not guarantee timely detection of one or more Lynch-related cancers at a treatable stage. The PROTECT-lynch study may change this with its preventive dendritic cell therapy. To prepare the intended dendritic cell (DC) product for the PROTECT-lynch study, several different short GMP peptides are required in drug substance (Active Pharmaceutical Ingredient, API) quality. As the Medical BioSciences department, we have extensive experience in the preparation of DC products in collaboration with the Pharmacy department, in which comparable peptides were present as important active substances. The specific peptides are always selected based on suitable targets in the intended patient population for which the treatment is being developed. In the case of the PROT…

Officiële publicaties

• TENDERNED · 368193 · 20 februari 2025
• TED · 114557-2025

Veelgestelde vragen

Wie is de aanbestedende dienst van deze aanbesteding?

De aanbestedende dienst is Radboud universitair medisch centrum (Nederland).

Hoe kan ik inschrijven op aanbestedingen in Nederland?

Inschrijvingen worden ingediend via het officiële aanbestedingsplatform in Nederland. El Vínculo helpt u aanbestedingen te vinden en de documenten te analyseren; de indiening gebeurt altijd bij de officiële bron.